{"id":60190,"date":"2026-02-06T17:40:45","date_gmt":"2026-02-06T08:40:45","guid":{"rendered":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/"},"modified":"2026-02-24T10:26:35","modified_gmt":"2026-02-24T01:26:35","slug":"aminoglycosides-market-imarc","status":"publish","type":"post","link":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/","title":{"rendered":"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033"},"content":{"rendered":"

\"Market<\/p>\n

1 \u5e8f\u6587
\n2 \u7bc4\u56f2\u3068\u65b9\u6cd5\u8ad6
\n2.1 \u8abf\u67fb\u76ee\u7684
\n2.2 \u95a2\u4fc2\u8005
\n2.3 \u30c7\u30fc\u30bf\u30bd\u30fc\u30b9
\n2.3.1 \u4e00\u6b21\u60c5\u5831\u6e90
\n2.3.2 \u4e8c\u6b21\u60c5\u5831\u6e90
\n2.4 \u5e02\u5834\u63a8\u5b9a
\n2.4.1 \u30dc\u30c8\u30e0\u30a2\u30c3\u30d7\u30a2\u30d7\u30ed\u30fc\u30c1
\n2.4.2 \u30c8\u30c3\u30d7\u30c0\u30a6\u30f3\u30a2\u30d7\u30ed\u30fc\u30c1
\n2.5 \u4e88\u6e2c\u65b9\u6cd5\u8ad6
\n3 \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc
\n4 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 – \u5e8f\u8ad6
\n4.1 \u6982\u8981
\n4.2 \u5e02\u5834\u52d5\u5411
\n4.3 \u696d\u754c\u30c8\u30ec\u30f3\u30c9
\n4.4 \u7af6\u5408\u60c5\u5831
\n5 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834\u306e\u5c55\u671b
\n5.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n5.2 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 – \u88fd\u54c1\u5225\u5185\u8a33
\n6.1 \u30cd\u30aa\u30de\u30a4\u30b7\u30f3
\n6.1.1 \u6982\u8981
\n6.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.1.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.1.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.2 \u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3
\n6.2.1 \u6982\u8981
\n6.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.2.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.2.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.3 \u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3
\n6.3.1 \u6982\u8981
\n6.3.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.3.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.3.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.4 \u30a2\u30df\u30ab\u30b7\u30f3
\n6.4.1 \u6982\u8981
\n6.4.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.4.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.4.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.5 \u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3
\n6.5.1 \u6982\u8981
\n6.5.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.5.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.5.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.6 \u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3
\n6.6.1 \u6982\u8981
\n6.6.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.6.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.6.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.7 \u30ab\u30ca\u30de\u30a4\u30b7\u30f3
\n6.7.1 \u6982\u8981
\n6.7.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.7.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n6.7.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.8 \u305d\u306e\u4ed6
\n6.8.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n6.8.2 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n6.9 \u88fd\u54c1\u5225\u9b45\u529b\u7684\u306a\u6295\u8cc7\u63d0\u6848
\n7 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 – \u6295\u4e0e\u7d4c\u8def\u5225\u5185\u8a33
\n7.1 \u6ce8\u5c04\u5264 (\u975e\u7d4c\u53e3)
\n7.1.1 \u6982\u8981
\n7.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n7.1.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n7.1.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n7.2 \u4e73\u623f\u5185
\n7.2.1 \u6982\u8981
\n7.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n7.2.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n7.2.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n7.3 \u5c40\u6240
\n7.3.1 \u6982\u8981
\n7.3.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n7.3.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n7.3.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n7.4 \u7d4c\u53e3
\n7.4.1 \u6982\u8981
\n7.4.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n7.4.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n7.4.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n7.5 \u305d\u306e\u4ed6
\n7.5.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n7.5.2 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n7.6 \u6295\u4e0e\u7d4c\u8def\u5225\u9b45\u529b\u7684\u306a\u6295\u8cc7\u63d0\u6848
\n8 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 – \u7528\u9014\u5225\u5185\u8a33
\n8.1 \u7363\u533b\u7528
\n8.1.1 \u6982\u8981
\n8.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n8.1.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n8.1.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n8.2 \u76ae\u819a\u611f\u67d3\u75c7
\n8.2.1 \u6982\u8981
\n8.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n8.2.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n8.2.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n8.3 \u547c\u5438\u5668\u75be\u60a3
\n8.3.1 \u6982\u8981
\n8.3.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n8.3.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n8.3.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n8.4 \u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3
\n8.4.1 \u6982\u8981
\n8.4.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n8.4.3 \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3
\n8.4.4 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n8.5 \u305d\u306e\u4ed6
\n8.5.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n8.5.2 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n8.6 \u7528\u9014\u5225\u9b45\u529b\u7684\u306a\u6295\u8cc7\u63d0\u6848
\n9 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 – \u5730\u57df\u5225\u5185\u8a33
\n9.1 \u5317\u7c73
\n9.1.1 \u7c73\u56fd
\n9.1.1.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.1.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n9.1.1.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.1.1.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.1.1.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.1.1.6 \u4e3b\u8981\u4f01\u696d
\n9.1.1.7 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n9.1.2 \u30ab\u30ca\u30c0
\n9.1.2.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.1.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9 (2019-2024)
\n9.1.2.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.1.2.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.1.2.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.1.2.6 \u4e3b\u8981\u4f01\u696d
\n9.1.2.7 \u5e02\u5834\u4e88\u6e2c (2025-2033)
\n9.2 \u30e8\u30fc\u30ed\u30c3\u30d1
\n9.2.1 \u30c9\u30a4\u30c4
\n9.2.1.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.2.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.2.1.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.2.1.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.2.1.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.2.1.6 \u4e3b\u8981\u4f01\u696d
\n9.2.1.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.2.2 \u30d5\u30e9\u30f3\u30b9
\n9.2.2.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.2.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.2.2.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.2.2.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.2.2.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.2.2.6 \u4e3b\u8981\u4f01\u696d
\n9.2.2.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.2.3 \u30a4\u30ae\u30ea\u30b9
\n9.2.3.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.2.3.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.2.3.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.2.3.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.2.3.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.2.3.6 \u4e3b\u8981\u4f01\u696d
\n9.2.3.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.2.4 \u30a4\u30bf\u30ea\u30a2
\n9.2.4.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.2.4.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.2.4.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.2.4.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.2.4.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.2.4.6 \u4e3b\u8981\u4f01\u696d
\n9.2.4.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.2.5 \u30b9\u30da\u30a4\u30f3
\n9.2.5.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.2.5.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.2.5.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.2.5.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.2.5.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.2.5.6 \u4e3b\u8981\u4f01\u696d
\n9.2.5.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.2.6 \u305d\u306e\u4ed6
\n9.2.6.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.2.6.2 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b
\n9.3.1 \u4e2d\u56fd
\n9.3.1.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.3.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.1.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.3.1.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.3.1.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.3.1.6 \u4e3b\u8981\u4f01\u696d
\n9.3.1.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3.2 \u65e5\u672c
\n9.3.2.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.3.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.2.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.3.2.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.3.2.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.3.2.6 \u4e3b\u8981\u4f01\u696d
\n9.3.2.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3.3 \u30a4\u30f3\u30c9
\n9.3.3.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.3.3.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.3.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.3.3.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.3.3.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.3.3.6 \u4e3b\u8981\u4f01\u696d
\n9.3.3.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3.4 \u97d3\u56fd
\n9.3.4.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.3.4.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.4.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.3.4.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.3.4.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.3.4.6 \u4e3b\u8981\u4f01\u696d
\n9.3.4.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3.5 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2
\n9.3.5.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.3.5.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.5.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.3.5.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.3.5.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.3.5.6 \u4e3b\u8981\u4f01\u696d
\n9.3.5.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3.6 \u30a4\u30f3\u30c9\u30cd\u30b7\u30a2
\n9.3.6.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.3.6.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.6.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.3.6.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.3.6.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.3.6.6 \u4e3b\u8981\u4f01\u696d
\n9.3.6.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.3.7 \u305d\u306e\u4ed6
\n9.3.7.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.3.7.2 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.4 \u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab
\n9.4.1 \u30d6\u30e9\u30b8\u30eb
\n9.4.1.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.4.1.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.4.1.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.4.1.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.4.1.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.4.1.6 \u4e3b\u8981\u4f01\u696d
\n9.4.1.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.4.2 \u30e1\u30ad\u30b7\u30b3
\n9.4.2.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.4.2.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.4.2.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.4.2.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.4.2.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.4.2.6 \u4e3b\u8981\u4f01\u696d
\n9.4.2.7 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.4.3 \u305d\u306e\u4ed6
\n9.4.3.1 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019-2024\u5e74)
\n9.4.3.2 \u5e02\u5834\u4e88\u6e2c (2025-2033\u5e74)
\n9.5 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab
\n9.5.1 \u5e02\u5834\u4fc3\u9032\u8981\u56e0
\n9.5.2 \u904e\u53bb\u304a\u3088\u3073\u73fe\u5728\u306e\u5e02\u5834\u52d5\u5411 (2019\u5e74\uff5e2024\u5e74)
\n9.5.3 \u88fd\u54c1\u5225\u5e02\u5834\u5185\u8a33
\n9.5.4 \u6295\u4e0e\u7d4c\u8def\u5225\u5e02\u5834\u5185\u8a33
\n9.5.5 \u7528\u9014\u5225\u5e02\u5834\u5185\u8a33
\n9.5.6 \u56fd\u5225\u5e02\u5834\u5185\u8a33
\n9.5.7 \u4e3b\u8981\u4f01\u696d
\n9.5.8 \u5e02\u5834\u4e88\u6e2c (2025\u5e74\uff5e2033\u5e74)
\n9.6 \u5730\u57df\u5225\u9b45\u529b\u7684\u306a\u6295\u8cc7\u6a5f\u4f1a
\n10 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 \u2013 \u7af6\u4e89\u74b0\u5883
\n10.1 \u6982\u8981
\n10.2 \u5e02\u5834\u69cb\u9020
\n10.3 \u4e3b\u8981\u4f01\u696d\u5225\u5e02\u5834\u30b7\u30a7\u30a2
\n10.4 \u5e02\u5834\u30d7\u30ec\u30fc\u30e4\u30fc\u306e\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0
\n10.5 \u4e3b\u8981\u306a\u6210\u529f\u6226\u7565
\n10.6 \u7af6\u4e89\u30c0\u30c3\u30b7\u30e5\u30dc\u30fc\u30c9
\n10.7 \u4f01\u696d\u8a55\u4fa1\u8c61\u9650
\n11 \u4e3b\u8981\u4f01\u696d\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb
\n11.1 Huvepharma NV
\n11.1.1 \u4e8b\u696d\u6982\u8981
\n11.1.2 \u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa
\n11.1.3 \u4e8b\u696d\u6226\u7565
\n11.1.4 SWOT\u5206\u6790
\n11.1.5 \u4e3b\u8981\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u30a4\u30d9\u30f3\u30c8
\n11.2 Kremoint Pharma Pvt. Ltd.
\n11.2.1 \u4e8b\u696d\u6982\u8981
\n11.2.2 \u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa
\n11.2.3 \u4e8b\u696d\u6226\u7565
\n11.2.4 SWOT\u5206\u6790
\n11.2.5 \u4e3b\u8981\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u30a4\u30d9\u30f3\u30c8
\n11.3 Novartis AG
\n11.3.1 \u4e8b\u696d\u6982\u8981
\n11.3.2 \u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa
\n11.3.3 \u4e8b\u696d\u6226\u7565
\n11.3.4 SWOT\u5206\u6790
\n11.3.5 \u4e3b\u8981\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u30a4\u30d9\u30f3\u30c8
\n11.4 Pfizer Inc.
\n11.4.1 \u4e8b\u696d\u6982\u8981
\n11.4.2 \u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa
\n11.4.3 \u4e8b\u696d\u6226\u7565
\n11.4.4 SWOT\u5206\u6790
\n11.4.5 \u4e3b\u8981\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u30a4\u30d9\u30f3\u30c8
\n11.5 Teva Pharmaceutical Industries Ltd
\n11.5.1 \u4e8b\u696d\u6982\u8981
\n11.5.2 \u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa
\n11.5.3 \u4e8b\u696d\u6226\u7565
\n11.5.4 SWOT\u5206\u6790
\n11.5.5 \u4e3b\u8981\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u30a4\u30d9\u30f3\u30c8
\n11.6 Vega Group company limited
\n11.6.1 \u4e8b\u696d\u6982\u8981
\n11.6.2 \u88fd\u54c1\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa
\n11.6.3 \u4e8b\u696d\u6226\u7565
\n11.6.4 SWOT\u5206\u6790
\n11.6.5 \u4e3b\u8981\u306a\u30cb\u30e5\u30fc\u30b9\u3068\u30a4\u30d9\u30f3\u30c8
\n\u3053\u308c\u306f\u4f01\u696d\u306e\u90e8\u5206\u7684\u306a\u30ea\u30b9\u30c8\u3067\u3042\u308a\u3001\u5b8c\u5168\u306a\u30ea\u30b9\u30c8\u306f\u30ec\u30dd\u30fc\u30c8\u306b\u8a18\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002
\n12 \u4e16\u754c\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u5e02\u5834 \u2013 \u696d\u754c\u5206\u6790
\n12.1 \u63a8\u9032\u8981\u56e0\u3001\u963b\u5bb3\u8981\u56e0\u3001\u304a\u3088\u3073\u6a5f\u4f1a
\n12.1.1 \u6982\u8981
\n12.1.2 \u63a8\u9032\u8981\u56e0
\n12.1.3 \u963b\u5bb3\u8981\u56e0
\n12.1.4 \u6a5f\u4f1a
\n12.1.5 \u5f71\u97ff\u5206\u6790
\n12.2 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790
\n12.2.1 \u6982\u8981
\n12.2.2 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b
\n12.2.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b
\n12.2.4 \u7af6\u4e89\u306e\u7a0b\u5ea6
\n12.2.5 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01
\n12.2.6 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01
\n12.3 \u30d0\u30ea\u30e5\u30fc\u30c1\u30a7\u30fc\u30f3\u5206\u6790
\n13 \u6226\u7565\u7684\u63d0\u8a00
\n14 \u4ed8\u9332<\/p>\n","protected":false},"excerpt":{"rendered":"

\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u306e\u4e16\u754c\u5e02\u5834\u306f\u30012024\u5e74\u306b16.7\u5104\u7c73\u30c9\u30eb\u898f\u6a21\u306b\u9054\u3057\u307e\u3057\u305f\u3002IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u4e88\u6e2c\u306b\u3088\u308b\u3068\u30012033\u5e74\u306b\u306f21.2\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012025\u5e74\u304b\u30892033\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff092.4%\u3067\u63a8\u79fb\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002<\/p>\n

\u3053\u306e\u5e02\u5834\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u8981\u306a\u8981\u56e0\u306f\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u307e\u305a\u3001\u7d50\u6838\u306e\u767a\u751f\u7387\u5897\u52a0\u304c\u5e02\u5834\u3092\u523a\u6fc0\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u7d30\u83cc\u611f\u67d3\u75c7\u306b\u304b\u304b\u308a\u3084\u3059\u3044\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3067\u3059\u3002\u3055\u3089\u306b\u3001\u52b9\u679c\u7684\u306a\u52d5\u7269\u533b\u7642\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u9700\u8981\u306e\u9ad8\u307e\u308a\u3084\u3001\u7d99\u7d9a\u7684\u306a\u88fd\u5264\u6280\u8853\u306e\u9032\u6b69\u3082\u5e02\u5834\u306e\u62e1\u5927\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u3057\u3066\u306f\u3001\u500b\u5225\u5316\u533b\u7642\u306e\u9032\u5c55\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u8a3a\u65ad\u304a\u3088\u3073\u30b2\u30ce\u30df\u30af\u30b9\u30c4\u30fc\u30eb\u306e\u9032\u6b69\u306b\u3088\u308a\u3001\u533b\u7642\u63d0\u4f9b\u8005\u306f\u60a3\u8005\u3054\u3068\u306b\u6700\u3082\u52b9\u679c\u7684\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u3092\u7279\u5b9a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u8033\u6bd2\u6027\u3084\u814e\u6bd2\u6027\u3068\u3044\u3063\u305f\u526f\u4f5c\u7528\u306e\u30ea\u30b9\u30af\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e743\u6708\u306b\u306fInsmed Incorporated\u304c\u3001\u30b5\u30f3\u30c7\u30a3\u30a8\u30b4\u3067\u958b\u50ac\u3055\u308c\u305f\u7c73\u56fd\u80f8\u90e8\u5b66\u4f1a\uff08ATS\uff092024\u56fd\u969b\u4f1a\u8b70\u3067\u3001\u6297\u751f\u7269\u8cea\u672a\u958b\u59cb\u306e\u518d\u767a\u6027\u307e\u305f\u306f\u65b0\u898f\u8a3a\u65ad\u306e\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\uff08MAC\uff09\u80ba\u75be\u60a3\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fARIKAYCE\u00ae\u306eARISE\u7814\u7a76\u304b\u3089\u306e\u5fae\u751f\u7269\u5b66\u7684\u30c7\u30fc\u30bf\u3092\u542b\u30809\u3064\u306e\u6284\u9332\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u898f\u5236\u74b0\u5883\u306e\u5f37\u5316\u3082\u5e02\u5834\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u88fd\u85ac\u4f1a\u793e\u3084\u898f\u5236\u6a5f\u95a2\u306f\u3001\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u306e\u4f7f\u7528\u306b\u304a\u3051\u308b\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3068\u5b89\u5168\u6027\u306e\u5411\u4e0a\u306b\u6ce8\u529b\u3057\u3066\u304a\u308a\u3001\u6295\u4e0e\u91cf\u306e\u6700\u9069\u5316\u3068\u6709\u5bb3\u4e8b\u8c61\u306e\u6700\u5c0f\u5316\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u3057\u3044\u30d7\u30ed\u30c8\u30b3\u30eb\u3084\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u5c0e\u5165\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e742\u6708\u306b\u306f\u3001Cipla Limited\u304c\u30a4\u30f3\u30c9\u306e\u4e2d\u592e\u533b\u85ac\u54c1\u6a19\u6e96\u7ba1\u7406\u6a5f\u69cb\uff08CDSCO\uff09\u304b\u3089\u3001\u65b0\u898f\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u9759\u8108\u5185\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u30d7\u30e9\u30be\u30de\u30a4\u30b7\u30f3\u306e\u8ca9\u58f2\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u5168\u4f53\u306e\u5c55\u671b\u3092\u63a8\u9032\u3059\u308b\u52d5\u304d\u3067\u3059\u3002<\/p>\n

\u3055\u3089\u306b\u3001\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u3092\u542b\u3080\u4f75\u7528\u7642\u6cd5\u304c\u3001\u6cbb\u7642\u52b9\u679c\u306e\u5411\u4e0a\u3068\u6297\u751f\u7269\u8cea\u8010\u6027\u3078\u306e\u5bfe\u7b56\u3068\u3057\u3066\u6ce8\u76ee\u3092\u96c6\u3081\u3066\u3044\u307e\u3059\u3002\u4ed6\u306e\u6297\u751f\u7269\u8cea\u3068\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u533b\u7642\u63d0\u4f9b\u8005\u306f\u8907\u6570\u306e\u7d30\u83cc\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u6a19\u7684\u3068\u3057\u3001\u8010\u6027\u767a\u751f\u306e\u53ef\u80fd\u6027\u3092\u4f4e\u6e1b\u3067\u304d\u307e\u3059\u30022024\u5e747\u6708\u306b\u306f\u3001Orchid Pharma Limited\u304c\u3001\u8907\u96d1\u306a\u9662\u5185\u80ba\u708e\uff08HAP\uff09\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\uff08cUTI\uff09\u3001\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\uff08VAP\uff09\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u65b0\u85acCefepime-Enmetazobactam\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u5730\u7406\u7684\u30c8\u30ec\u30f3\u30c9\u3092\u898b\u308b\u3068\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u52b9\u679c\u7684\u306a\u6297\u83cc\u6cbb\u7642\u9078\u629e\u80a2\u306e\u666e\u53ca\u3068\u3001\u4fa1\u5024\u3042\u308b\u6cbb\u7642\u85ac\u3078\u306e\u9700\u8981\u5897\u52a0\u304c\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u5e02\u5834\u306b\u304a\u3051\u308b\u8ab2\u984c\u3068\u3057\u3066\u306f\u3001\u814e\u6bd2\u6027\u767a\u73fe\u306e\u30ea\u30b9\u30af\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u526f\u4f5c\u7528\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u52b9\u7387\u7684\u306a\u9001\u9054\u65b9\u6cd5\u306e\u5c0e\u5165\u304c\u3001\u4eca\u5f8c\u306e\u5e02\u5834\u3092\u727d\u5f15\u3059\u308b\u91cd\u8981\u306a\u6a5f\u4f1a\u3068\u306a\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u7af6\u4e89\u74b0\u5883\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd\u3001Vega Group company limited\u306a\u3069\u3001\u591a\u6570\u306e\u8457\u540d\u4f01\u696d\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u5206\u6790\u306b\u3088\u308b\u3068\u3001\u5e02\u5834\u306f\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u306b\u57fa\u3065\u3044\u3066\u5206\u985e\u3055\u308c\u307e\u3059\u3002\u88fd\u54c1\u5225\u3067\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u7279\u306b\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u3067\u6700\u5927\u306e\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u5831\u544a\u66f8\u306b\u3088\u308b\u3068\u3001\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u3001\u5730\u57df\u5225\u306b\u5e02\u5834\u304c\u7d30\u5206\u5316\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306e\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u88fd\u54c1\u5225\u5e02\u5834\u3067\u306f\u3001\u5f37\u529b\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u304c\u6700\u5927\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ab\u30c6\u30b4\u30ea\u30fc\u306b\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u3082\u542b\u307e\u308c\u307e\u3059\u3002Xellia Pharmaceuticals\u306f\u3001\u75c5\u9662\u74b0\u5883\u3067\u5e83\u304f\u63a1\u7528\u3055\u308c\u3066\u3044\u308b\u6ce8\u5c04\u5264\u3092\u542b\u3080\u3001\u591a\u69d8\u306a\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u88fd\u54c1\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u6295\u4e0e\u7d4c\u8def\u5225\u3067\u306f\u3001\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u9700\u8981\u306b\u304a\u3044\u3066\u5727\u5012\u7684\u306a\u512a\u4f4d\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u306f\u3001\u60a3\u8005\u306b\u3068\u3063\u3066\u3088\u308a\u5b89\u5168\u3067\u52b9\u679c\u7684\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3092\u958b\u767a\u3059\u308b\u5fc5\u8981\u6027\u306e\u9ad8\u307e\u308a\u306b\u3088\u3063\u3066\u727d\u5f15\u3055\u308c\u3066\u304a\u308a\u3001\u4f8b\u3048\u3070Hikma Pharmaceuticals\u306f\u6551\u547d\u6551\u6025\u74b0\u5883\u5411\u3051\u306e\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def\u306b\u306f\u3001\u4e73\u623f\u5185\u6295\u4e0e\u3001\u5c40\u6240\u6295\u4e0e\u3001\u7d4c\u53e3\u6295\u4e0e\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n

\u7528\u9014\u5225\u5e02\u5834\u3067\u306f\u3001\u547c\u5438\u5668\u75be\u60a3\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u53ce\u76ca\u306b\u304a\u3044\u3066\u6700\u5927\u306e\u5272\u5408\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u547c\u5438\u5668\u75be\u60a3\u3068\u306e\u95d8\u3044\u306b\u5bfe\u3059\u308b\u4e16\u754c\u7684\u306a\u8981\u6c42\u306e\u9ad8\u307e\u308a\u304c\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u304a\u308a\u3001\u3053\u308c\u3089\u306e\u6297\u751f\u7269\u8cea\u3092\u80ba\u306b\u76f4\u63a5\u9001\u9054\u3059\u308b\u6700\u9069\u5316\u3082\u76ee\u6307\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u306b\u306f\u3001\u7363\u533b\u7528\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u306a\u3069\u306e\u7528\u9014\u3082\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u5730\u57df\u5225\u5e02\u5834\u5206\u6790\u3067\u306f\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u5e02\u5834\u306b\u304a\u3044\u3066\u660e\u78ba\u306a\u512a\u4f4d\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5730\u57df\u306f\u3001\u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u306a\u3069\uff09\u3001\u4e2d\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30e1\u30ad\u30b7\u30b3\u306a\u3069\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3068\u3044\u3063\u305f\u4e3b\u8981\u5e02\u5834\u3068\u3068\u3082\u306b\u5305\u62ec\u7684\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u6162\u6027\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u767a\u751f\u7387\u5897\u52a0\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u6210\u9577\u3092\u5f37\u529b\u306b\u63a8\u9032\u3057\u3066\u304a\u308a\u3001\u6025\u901f\u306b\u62e1\u5927\u3059\u308b\u88fd\u85ac\u7523\u696d\u3082\u91cd\u8981\u306a\u6210\u9577\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002IMARC\u306e\u5831\u544a\u306b\u3088\u308b\u3068\u3001\u30a4\u30f3\u30c9\u306e\u88fd\u85ac\u5e02\u5834\u898f\u6a21\u306f2023\u5e74\u306b546\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012024\u5e74\u304b\u30892032\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0912.3%\u3067\u6210\u9577\u3057\u30012032\u5e74\u306b\u306f1631\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u7af6\u4e89\u74b0\u5883\u3068\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u65b0\u3057\u3044\u6295\u4e0e\u65b9\u6cd5\u306e\u958b\u767a\u3001\u65b0\u898f\u7528\u9014\u306e\u63a2\u6c42\u3001\u65e2\u5b58\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u88fd\u5264\u306e\u6539\u5584\u3078\u306e\u7a4d\u6975\u7684\u306a\u6295\u8cc7\u304c\u5e02\u5834\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4f01\u696d\u306f\u307e\u305f\u3001\u88fd\u54c1\u306e\u5b89\u5168\u6027\u3092\u8a55\u4fa1\u3059\u308b\u305f\u3081\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u7cbe\u529b\u7684\u306b\u5b9f\u65bd\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u5168\u4f53\u306e\u5c55\u671b\u306b\u826f\u3044\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd.\u3001Vega Group company limited\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n

\u6700\u8fd1\u306e\u52d5\u5411\u3068\u3057\u3066\u30012024\u5e747\u6708\u306b\u306f\u3001Orchid Pharma Limited\u304c\u8907\u96d1\u306a\u611f\u67d3\u75c7\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u65b0\u85acCefepime-Enmetazobactam\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u306f\u3001\u6700\u8fd1\u306e\u52d5\u5411\u3068\u3057\u3066\u30012024\u5e743\u6708\u306bInsmed\u793e\u304c\u7c73\u56fd\u80f8\u90e8\u5b66\u4f1a\uff08ATS\uff092024\u56fd\u969b\u4f1a\u8b70\u3067\u3001\u6297\u751f\u7269\u8cea\u672a\u6295\u4e0e\u306e\u518d\u767a\u6027\u307e\u305f\u306f\u65b0\u898f\u8a3a\u65ad\u306e\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\uff08MAC\u80ba\u75be\u60a3\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fARIKAYCE\u00ae\uff08\u30a2\u30df\u30ab\u30b7\u30f3\u30ea\u30dd\u30bd\u30fc\u30e0\u5438\u5165\u61f8\u6fc1\u6db2\uff09\u306eARISE\u8a66\u9a13\u306e\u5fae\u751f\u7269\u5b66\u7684\u30c7\u30fc\u30bf\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u30012024\u5e742\u6708\u306b\u306f\u3001Cipla\u793e\u304c\u30a4\u30f3\u30c9\u3067\u65b0\u898f\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u9759\u8108\u5185\u6295\u4e0e\u306e\u30d7\u30e9\u30be\u30de\u30a4\u30b7\u30f3\u306b\u3064\u3044\u3066\u3001\u9662\u5185\u80ba\u708e\uff08HAP\uff09\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\uff08cUTI\uff09\u3001\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\uff08VAP\uff09\u306e\u9069\u5fdc\u3067\u4e2d\u592e\u533b\u85ac\u54c1\u57fa\u6e96\u7ba1\u7406\u6a5f\u69cb\uff08CDSCO\uff09\u306e\u627f\u8a8d\u3092\u53d7\u3051\u3001\u8ca9\u58f2\u4fc3\u9032\u304c\u53ef\u80fd\u3068\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n

\u3053\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u30ec\u30dd\u30fc\u30c8\u306f\u30012024\u5e74\u3092\u57fa\u6e96\u5e74\u3068\u3057\u30012019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u904e\u53bb\u306e\u671f\u9593\u3068\u30012025\u5e74\u304b\u30892033\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u671f\u9593\u3092\u5bfe\u8c61\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u898f\u6a21\u306f\u6570\u5341\u5104\u7c73\u30c9\u30eb\u5358\u4f4d\u3067\u8a55\u4fa1\u3055\u308c\u3001\u904e\u53bb\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u5e02\u5834\u898b\u901a\u3057\u3001\u696d\u754c\u306e\u4fc3\u9032\u8981\u56e0\u3068\u8ab2\u984c\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u306e\u904e\u53bb\u304a\u3088\u3073\u4e88\u6e2c\u5e02\u5834\u8a55\u4fa1\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u307e\u3059\u3002<\/p>\n

\u30ec\u30dd\u30fc\u30c8\u3067\u30ab\u30d0\u30fc\u3055\u308c\u308b\u88fd\u54c1\u306b\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u6295\u4e0e\u7d4c\u8def\u306f\u3001\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u6295\u4e0e\u3001\u5c40\u6240\u6295\u4e0e\u3001\u7d4c\u53e3\u6295\u4e0e\u3001\u305d\u306e\u4ed6\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u4e3b\u306a\u7528\u9014\u3068\u3057\u3066\u306f\u3001\u7363\u533b\u5206\u91ce\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u304c\u5bfe\u8c61\u3068\u306a\u308a\u3001\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u97d3\u56fd\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u30a4\u30f3\u30c9\u30cd\u30b7\u30a2\u3001\u30d6\u30e9\u30b8\u30eb\u3001\u30e1\u30ad\u30b7\u30b3\u3068\u3044\u3063\u305f\u4e3b\u8981\u56fd\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u307e\u3059\u3002<\/p>\n

\u5e02\u5834\u306e\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd\u3001Vega Group company limited\u306a\u3069\u304c\u540d\u3092\u9023\u306d\u3066\u3044\u307e\u3059\u3002<\/p>\n

\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u304c\u3053\u308c\u307e\u3067\u3069\u306e\u3088\u3046\u306b\u63a8\u79fb\u3057\u3001\u4eca\u5f8c\u3069\u306e\u3088\u3046\u306b\u5c55\u958b\u3059\u308b\u304b\u3001\u5e02\u5834\u306e\u4fc3\u9032\u8981\u56e0\u3001\u6291\u5236\u8981\u56e0\u3001\u6a5f\u4f1a\u3001\u304a\u3088\u3073\u305d\u308c\u3089\u304c\u5e02\u5834\u6210\u9577\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u6df1\u304f\u6398\u308a\u4e0b\u3052\u307e\u3059\u3002\u307e\u305f\u3001\u4e3b\u8981\u306a\u5730\u57df\u5e02\u5834\u3001\u6700\u3082\u9b45\u529b\u7684\u306a\u56fd\u3001\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u5225\u306e\u5e02\u5834\u306e\u5185\u8a33\u3001\u304a\u3088\u3073\u305d\u308c\u305e\u308c\u306e\u6700\u3082\u9b45\u529b\u7684\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u7279\u5b9a\u3057\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u306e\u7af6\u4e89\u69cb\u9020\u3068\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u3064\u3044\u3066\u3082\u8a73\u7d30\u306b\u89e3\u8aac\u3057\u307e\u3059\u3002<\/p>\n

\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306f\u3001IMARC\u306e\u30ec\u30dd\u30fc\u30c8\u3092\u901a\u3058\u3066\u30012019\u5e74\u304b\u30892033\u5e74\u307e\u3067\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5b9a\u91cf\u7684\u5206\u6790\u3001\u6700\u65b0\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3001\u4e88\u6e2c\u3001\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3092\u5f97\u3089\u308c\u307e\u3059\u3002\u5e02\u5834\u306e\u4fc3\u9032\u8981\u56e0\u3001\u8ab2\u984c\u3001\u6a5f\u4f1a\u306b\u95a2\u3059\u308b\u60c5\u5831\u306b\u52a0\u3048\u3001\u4e3b\u8981\u306a\u5730\u57df\u304a\u3088\u3073\u56fd\u30ec\u30d9\u30eb\u306e\u5e02\u5834\u3092\u7279\u5b9a\u3067\u304d\u307e\u3059\u3002\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u306b\u3088\u308a\u3001\u65b0\u898f\u53c2\u5165\u8005\u3001\u7af6\u4e89\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u30fb\u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3092\u8a55\u4fa1\u3057\u3001\u696d\u754c\u306e\u7af6\u4e89\u30ec\u30d9\u30eb\u3068\u9b45\u529b\u3092\u5206\u6790\u53ef\u80fd\u3067\u3059\u3002\u307e\u305f\u3001\u7af6\u4e89\u74b0\u5883\u306e\u5206\u6790\u3092\u901a\u3058\u3066\u3001\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306e\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u306e\u4f4d\u7f6e\u3092\u7406\u89e3\u3057\u3001\u7af6\u4e89\u6226\u7565\u3092\u7b56\u5b9a\u3059\u308b\u305f\u3081\u306e\u6d1e\u5bdf\u3092\u5f97\u3089\u308c\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"yoast_head":"\n\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033\" \/>\n<meta property=\"og:description\" content=\"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u306e\u4e16\u754c\u5e02\u5834\u306f\u30012024\u5e74\u306b16.7\u5104\u7c73\u30c9\u30eb\u898f\u6a21\u306b\u9054\u3057\u307e\u3057\u305f\u3002IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u4e88\u6e2c\u306b\u3088\u308b\u3068\u30012033\u5e74\u306b\u306f21.2\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012025\u5e74\u304b\u30892033\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff092.4%\u3067\u63a8\u79fb\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002 \u3053\u306e\u5e02\u5834\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u8981\u306a\u8981\u56e0\u306f\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u307e\u305a\u3001\u7d50\u6838\u306e\u767a\u751f\u7387\u5897\u52a0\u304c\u5e02\u5834\u3092\u523a\u6fc0\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u7d30\u83cc\u611f\u67d3\u75c7\u306b\u304b\u304b\u308a\u3084\u3059\u3044\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3067\u3059\u3002\u3055\u3089\u306b\u3001\u52b9\u679c\u7684\u306a\u52d5\u7269\u533b\u7642\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u9700\u8981\u306e\u9ad8\u307e\u308a\u3084\u3001\u7d99\u7d9a\u7684\u306a\u88fd\u5264\u6280\u8853\u306e\u9032\u6b69\u3082\u5e02\u5834\u306e\u62e1\u5927\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002 \u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u3057\u3066\u306f\u3001\u500b\u5225\u5316\u533b\u7642\u306e\u9032\u5c55\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u8a3a\u65ad\u304a\u3088\u3073\u30b2\u30ce\u30df\u30af\u30b9\u30c4\u30fc\u30eb\u306e\u9032\u6b69\u306b\u3088\u308a\u3001\u533b\u7642\u63d0\u4f9b\u8005\u306f\u60a3\u8005\u3054\u3068\u306b\u6700\u3082\u52b9\u679c\u7684\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u3092\u7279\u5b9a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u8033\u6bd2\u6027\u3084\u814e\u6bd2\u6027\u3068\u3044\u3063\u305f\u526f\u4f5c\u7528\u306e\u30ea\u30b9\u30af\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e743\u6708\u306b\u306fInsmed Incorporated\u304c\u3001\u30b5\u30f3\u30c7\u30a3\u30a8\u30b4\u3067\u958b\u50ac\u3055\u308c\u305f\u7c73\u56fd\u80f8\u90e8\u5b66\u4f1a\uff08ATS\uff092024\u56fd\u969b\u4f1a\u8b70\u3067\u3001\u6297\u751f\u7269\u8cea\u672a\u958b\u59cb\u306e\u518d\u767a\u6027\u307e\u305f\u306f\u65b0\u898f\u8a3a\u65ad\u306e\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\uff08MAC\uff09\u80ba\u75be\u60a3\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fARIKAYCE\u00ae\u306eARISE\u7814\u7a76\u304b\u3089\u306e\u5fae\u751f\u7269\u5b66\u7684\u30c7\u30fc\u30bf\u3092\u542b\u30809\u3064\u306e\u6284\u9332\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002 \u898f\u5236\u74b0\u5883\u306e\u5f37\u5316\u3082\u5e02\u5834\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u88fd\u85ac\u4f1a\u793e\u3084\u898f\u5236\u6a5f\u95a2\u306f\u3001\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u306e\u4f7f\u7528\u306b\u304a\u3051\u308b\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3068\u5b89\u5168\u6027\u306e\u5411\u4e0a\u306b\u6ce8\u529b\u3057\u3066\u304a\u308a\u3001\u6295\u4e0e\u91cf\u306e\u6700\u9069\u5316\u3068\u6709\u5bb3\u4e8b\u8c61\u306e\u6700\u5c0f\u5316\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u3057\u3044\u30d7\u30ed\u30c8\u30b3\u30eb\u3084\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u5c0e\u5165\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e742\u6708\u306b\u306f\u3001Cipla Limited\u304c\u30a4\u30f3\u30c9\u306e\u4e2d\u592e\u533b\u85ac\u54c1\u6a19\u6e96\u7ba1\u7406\u6a5f\u69cb\uff08CDSCO\uff09\u304b\u3089\u3001\u65b0\u898f\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u9759\u8108\u5185\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u30d7\u30e9\u30be\u30de\u30a4\u30b7\u30f3\u306e\u8ca9\u58f2\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u5168\u4f53\u306e\u5c55\u671b\u3092\u63a8\u9032\u3059\u308b\u52d5\u304d\u3067\u3059\u3002 \u3055\u3089\u306b\u3001\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u3092\u542b\u3080\u4f75\u7528\u7642\u6cd5\u304c\u3001\u6cbb\u7642\u52b9\u679c\u306e\u5411\u4e0a\u3068\u6297\u751f\u7269\u8cea\u8010\u6027\u3078\u306e\u5bfe\u7b56\u3068\u3057\u3066\u6ce8\u76ee\u3092\u96c6\u3081\u3066\u3044\u307e\u3059\u3002\u4ed6\u306e\u6297\u751f\u7269\u8cea\u3068\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u533b\u7642\u63d0\u4f9b\u8005\u306f\u8907\u6570\u306e\u7d30\u83cc\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u6a19\u7684\u3068\u3057\u3001\u8010\u6027\u767a\u751f\u306e\u53ef\u80fd\u6027\u3092\u4f4e\u6e1b\u3067\u304d\u307e\u3059\u30022024\u5e747\u6708\u306b\u306f\u3001Orchid Pharma Limited\u304c\u3001\u8907\u96d1\u306a\u9662\u5185\u80ba\u708e\uff08HAP\uff09\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\uff08cUTI\uff09\u3001\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\uff08VAP\uff09\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u65b0\u85acCefepime-Enmetazobactam\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002 \u5730\u7406\u7684\u30c8\u30ec\u30f3\u30c9\u3092\u898b\u308b\u3068\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u52b9\u679c\u7684\u306a\u6297\u83cc\u6cbb\u7642\u9078\u629e\u80a2\u306e\u666e\u53ca\u3068\u3001\u4fa1\u5024\u3042\u308b\u6cbb\u7642\u85ac\u3078\u306e\u9700\u8981\u5897\u52a0\u304c\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002 \u5e02\u5834\u306b\u304a\u3051\u308b\u8ab2\u984c\u3068\u3057\u3066\u306f\u3001\u814e\u6bd2\u6027\u767a\u73fe\u306e\u30ea\u30b9\u30af\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u526f\u4f5c\u7528\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u52b9\u7387\u7684\u306a\u9001\u9054\u65b9\u6cd5\u306e\u5c0e\u5165\u304c\u3001\u4eca\u5f8c\u306e\u5e02\u5834\u3092\u727d\u5f15\u3059\u308b\u91cd\u8981\u306a\u6a5f\u4f1a\u3068\u306a\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u7af6\u4e89\u74b0\u5883\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd\u3001Vega Group company limited\u306a\u3069\u3001\u591a\u6570\u306e\u8457\u540d\u4f01\u696d\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002 IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u5206\u6790\u306b\u3088\u308b\u3068\u3001\u5e02\u5834\u306f\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u306b\u57fa\u3065\u3044\u3066\u5206\u985e\u3055\u308c\u307e\u3059\u3002\u88fd\u54c1\u5225\u3067\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u7279\u306b\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u3067\u6700\u5927\u306e\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002 \u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u5831\u544a\u66f8\u306b\u3088\u308b\u3068\u3001\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u3001\u5730\u57df\u5225\u306b\u5e02\u5834\u304c\u7d30\u5206\u5316\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306e\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u88fd\u54c1\u5225\u5e02\u5834\u3067\u306f\u3001\u5f37\u529b\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u304c\u6700\u5927\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ab\u30c6\u30b4\u30ea\u30fc\u306b\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u3082\u542b\u307e\u308c\u307e\u3059\u3002Xellia Pharmaceuticals\u306f\u3001\u75c5\u9662\u74b0\u5883\u3067\u5e83\u304f\u63a1\u7528\u3055\u308c\u3066\u3044\u308b\u6ce8\u5c04\u5264\u3092\u542b\u3080\u3001\u591a\u69d8\u306a\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u88fd\u54c1\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002 \u6295\u4e0e\u7d4c\u8def\u5225\u3067\u306f\u3001\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u9700\u8981\u306b\u304a\u3044\u3066\u5727\u5012\u7684\u306a\u512a\u4f4d\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u306f\u3001\u60a3\u8005\u306b\u3068\u3063\u3066\u3088\u308a\u5b89\u5168\u3067\u52b9\u679c\u7684\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3092\u958b\u767a\u3059\u308b\u5fc5\u8981\u6027\u306e\u9ad8\u307e\u308a\u306b\u3088\u3063\u3066\u727d\u5f15\u3055\u308c\u3066\u304a\u308a\u3001\u4f8b\u3048\u3070Hikma Pharmaceuticals\u306f\u6551\u547d\u6551\u6025\u74b0\u5883\u5411\u3051\u306e\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def\u306b\u306f\u3001\u4e73\u623f\u5185\u6295\u4e0e\u3001\u5c40\u6240\u6295\u4e0e\u3001\u7d4c\u53e3\u6295\u4e0e\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u3002 \u7528\u9014\u5225\u5e02\u5834\u3067\u306f\u3001\u547c\u5438\u5668\u75be\u60a3\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u53ce\u76ca\u306b\u304a\u3044\u3066\u6700\u5927\u306e\u5272\u5408\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u547c\u5438\u5668\u75be\u60a3\u3068\u306e\u95d8\u3044\u306b\u5bfe\u3059\u308b\u4e16\u754c\u7684\u306a\u8981\u6c42\u306e\u9ad8\u307e\u308a\u304c\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u304a\u308a\u3001\u3053\u308c\u3089\u306e\u6297\u751f\u7269\u8cea\u3092\u80ba\u306b\u76f4\u63a5\u9001\u9054\u3059\u308b\u6700\u9069\u5316\u3082\u76ee\u6307\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u306b\u306f\u3001\u7363\u533b\u7528\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u306a\u3069\u306e\u7528\u9014\u3082\u542b\u307e\u308c\u307e\u3059\u3002 \u5730\u57df\u5225\u5e02\u5834\u5206\u6790\u3067\u306f\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u5e02\u5834\u306b\u304a\u3044\u3066\u660e\u78ba\u306a\u512a\u4f4d\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5730\u57df\u306f\u3001\u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u306a\u3069\uff09\u3001\u4e2d\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30e1\u30ad\u30b7\u30b3\u306a\u3069\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3068\u3044\u3063\u305f\u4e3b\u8981\u5e02\u5834\u3068\u3068\u3082\u306b\u5305\u62ec\u7684\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u6162\u6027\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u767a\u751f\u7387\u5897\u52a0\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u6210\u9577\u3092\u5f37\u529b\u306b\u63a8\u9032\u3057\u3066\u304a\u308a\u3001\u6025\u901f\u306b\u62e1\u5927\u3059\u308b\u88fd\u85ac\u7523\u696d\u3082\u91cd\u8981\u306a\u6210\u9577\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002IMARC\u306e\u5831\u544a\u306b\u3088\u308b\u3068\u3001\u30a4\u30f3\u30c9\u306e\u88fd\u85ac\u5e02\u5834\u898f\u6a21\u306f2023\u5e74\u306b546\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012024\u5e74\u304b\u30892032\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0912.3%\u3067\u6210\u9577\u3057\u30012032\u5e74\u306b\u306f1631\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u7af6\u4e89\u74b0\u5883\u3068\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u65b0\u3057\u3044\u6295\u4e0e\u65b9\u6cd5\u306e\u958b\u767a\u3001\u65b0\u898f\u7528\u9014\u306e\u63a2\u6c42\u3001\u65e2\u5b58\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u88fd\u5264\u306e\u6539\u5584\u3078\u306e\u7a4d\u6975\u7684\u306a\u6295\u8cc7\u304c\u5e02\u5834\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4f01\u696d\u306f\u307e\u305f\u3001\u88fd\u54c1\u306e\u5b89\u5168\u6027\u3092\u8a55\u4fa1\u3059\u308b\u305f\u3081\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u7cbe\u529b\u7684\u306b\u5b9f\u65bd\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u5168\u4f53\u306e\u5c55\u671b\u306b\u826f\u3044\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd.\u3001Vega Group company limited\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002 \u6700\u8fd1\u306e\u52d5\u5411\u3068\u3057\u3066\u30012024\u5e747\u6708\u306b\u306f\u3001Orchid Pharma Limited\u304c\u8907\u96d1\u306a\u611f\u67d3\u75c7\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u65b0\u85acCefepime-Enmetazobactam\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002 \u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u306f\u3001\u6700\u8fd1\u306e\u52d5\u5411\u3068\u3057\u3066\u30012024\u5e743\u6708\u306bInsmed\u793e\u304c\u7c73\u56fd\u80f8\u90e8\u5b66\u4f1a\uff08ATS\uff092024\u56fd\u969b\u4f1a\u8b70\u3067\u3001\u6297\u751f\u7269\u8cea\u672a\u6295\u4e0e\u306e\u518d\u767a\u6027\u307e\u305f\u306f\u65b0\u898f\u8a3a\u65ad\u306e\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\uff08MAC\u80ba\u75be\u60a3\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fARIKAYCE\u00ae\uff08\u30a2\u30df\u30ab\u30b7\u30f3\u30ea\u30dd\u30bd\u30fc\u30e0\u5438\u5165\u61f8\u6fc1\u6db2\uff09\u306eARISE\u8a66\u9a13\u306e\u5fae\u751f\u7269\u5b66\u7684\u30c7\u30fc\u30bf\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u30012024\u5e742\u6708\u306b\u306f\u3001Cipla\u793e\u304c\u30a4\u30f3\u30c9\u3067\u65b0\u898f\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u9759\u8108\u5185\u6295\u4e0e\u306e\u30d7\u30e9\u30be\u30de\u30a4\u30b7\u30f3\u306b\u3064\u3044\u3066\u3001\u9662\u5185\u80ba\u708e\uff08HAP\uff09\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\uff08cUTI\uff09\u3001\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\uff08VAP\uff09\u306e\u9069\u5fdc\u3067\u4e2d\u592e\u533b\u85ac\u54c1\u57fa\u6e96\u7ba1\u7406\u6a5f\u69cb\uff08CDSCO\uff09\u306e\u627f\u8a8d\u3092\u53d7\u3051\u3001\u8ca9\u58f2\u4fc3\u9032\u304c\u53ef\u80fd\u3068\u306a\u308a\u307e\u3057\u305f\u3002 \u3053\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u30ec\u30dd\u30fc\u30c8\u306f\u30012024\u5e74\u3092\u57fa\u6e96\u5e74\u3068\u3057\u30012019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u904e\u53bb\u306e\u671f\u9593\u3068\u30012025\u5e74\u304b\u30892033\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u671f\u9593\u3092\u5bfe\u8c61\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u898f\u6a21\u306f\u6570\u5341\u5104\u7c73\u30c9\u30eb\u5358\u4f4d\u3067\u8a55\u4fa1\u3055\u308c\u3001\u904e\u53bb\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u5e02\u5834\u898b\u901a\u3057\u3001\u696d\u754c\u306e\u4fc3\u9032\u8981\u56e0\u3068\u8ab2\u984c\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u306e\u904e\u53bb\u304a\u3088\u3073\u4e88\u6e2c\u5e02\u5834\u8a55\u4fa1\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u307e\u3059\u3002 \u30ec\u30dd\u30fc\u30c8\u3067\u30ab\u30d0\u30fc\u3055\u308c\u308b\u88fd\u54c1\u306b\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u6295\u4e0e\u7d4c\u8def\u306f\u3001\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u6295\u4e0e\u3001\u5c40\u6240\u6295\u4e0e\u3001\u7d4c\u53e3\u6295\u4e0e\u3001\u305d\u306e\u4ed6\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u4e3b\u306a\u7528\u9014\u3068\u3057\u3066\u306f\u3001\u7363\u533b\u5206\u91ce\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u304c\u5bfe\u8c61\u3068\u306a\u308a\u3001\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u97d3\u56fd\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u30a4\u30f3\u30c9\u30cd\u30b7\u30a2\u3001\u30d6\u30e9\u30b8\u30eb\u3001\u30e1\u30ad\u30b7\u30b3\u3068\u3044\u3063\u305f\u4e3b\u8981\u56fd\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u307e\u3059\u3002 \u5e02\u5834\u306e\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd\u3001Vega Group company limited\u306a\u3069\u304c\u540d\u3092\u9023\u306d\u3066\u3044\u307e\u3059\u3002 \u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u304c\u3053\u308c\u307e\u3067\u3069\u306e\u3088\u3046\u306b\u63a8\u79fb\u3057\u3001\u4eca\u5f8c\u3069\u306e\u3088\u3046\u306b\u5c55\u958b\u3059\u308b\u304b\u3001\u5e02\u5834\u306e\u4fc3\u9032\u8981\u56e0\u3001\u6291\u5236\u8981\u56e0\u3001\u6a5f\u4f1a\u3001\u304a\u3088\u3073\u305d\u308c\u3089\u304c\u5e02\u5834\u6210\u9577\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u6df1\u304f\u6398\u308a\u4e0b\u3052\u307e\u3059\u3002\u307e\u305f\u3001\u4e3b\u8981\u306a\u5730\u57df\u5e02\u5834\u3001\u6700\u3082\u9b45\u529b\u7684\u306a\u56fd\u3001\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u5225\u306e\u5e02\u5834\u306e\u5185\u8a33\u3001\u304a\u3088\u3073\u305d\u308c\u305e\u308c\u306e\u6700\u3082\u9b45\u529b\u7684\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u7279\u5b9a\u3057\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u306e\u7af6\u4e89\u69cb\u9020\u3068\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u3064\u3044\u3066\u3082\u8a73\u7d30\u306b\u89e3\u8aac\u3057\u307e\u3059\u3002 \u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306f\u3001IMARC\u306e\u30ec\u30dd\u30fc\u30c8\u3092\u901a\u3058\u3066\u30012019\u5e74\u304b\u30892033\u5e74\u307e\u3067\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5b9a\u91cf\u7684\u5206\u6790\u3001\u6700\u65b0\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3001\u4e88\u6e2c\u3001\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3092\u5f97\u3089\u308c\u307e\u3059\u3002\u5e02\u5834\u306e\u4fc3\u9032\u8981\u56e0\u3001\u8ab2\u984c\u3001\u6a5f\u4f1a\u306b\u95a2\u3059\u308b\u60c5\u5831\u306b\u52a0\u3048\u3001\u4e3b\u8981\u306a\u5730\u57df\u304a\u3088\u3073\u56fd\u30ec\u30d9\u30eb\u306e\u5e02\u5834\u3092\u7279\u5b9a\u3067\u304d\u307e\u3059\u3002\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u306b\u3088\u308a\u3001\u65b0\u898f\u53c2\u5165\u8005\u3001\u7af6\u4e89\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u30fb\u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3092\u8a55\u4fa1\u3057\u3001\u696d\u754c\u306e\u7af6\u4e89\u30ec\u30d9\u30eb\u3068\u9b45\u529b\u3092\u5206\u6790\u53ef\u80fd\u3067\u3059\u3002\u307e\u305f\u3001\u7af6\u4e89\u74b0\u5883\u306e\u5206\u6790\u3092\u901a\u3058\u3066\u3001\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306e\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u306e\u4f4d\u7f6e\u3092\u7406\u89e3\u3057\u3001\u7af6\u4e89\u6226\u7565\u3092\u7b56\u5b9a\u3059\u308b\u305f\u3081\u306e\u6d1e\u5bdf\u3092\u5f97\u3089\u308c\u307e\u3059\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/\" \/>\n<meta property=\"og:site_name\" content=\"GlobalResearch.jp\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-06T08:40:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T01:26:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp\" \/>\n<meta name=\"author\" content=\"globalresearch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"globalresearch\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/\",\"url\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/\",\"name\":\"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033\",\"isPartOf\":{\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp\",\"datePublished\":\"2026-02-06T08:40:45+00:00\",\"dateModified\":\"2026-02-24T01:26:35+00:00\",\"author\":{\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#primaryimage\",\"url\":\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp\",\"contentUrl\":\"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/www.globalresearch.jp\/data\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#website\",\"url\":\"https:\/\/www.marketreport.jp\/insight\/\",\"name\":\"GlobalResearch.jp\",\"description\":\"\u2756\u30b0\u30ed\u30fc\u30d0\u30eb\u8abf\u67fb\u30ec\u30dd\u30fc\u30c8\u8ca9\u58f2\u30b5\u30a4\u30c8\u2756\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.marketreport.jp\/insight\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4\",\"name\":\"globalresearch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g\",\"caption\":\"globalresearch\"},\"sameAs\":[\"https:\/\/www.marketreport.jp\/insight\"],\"url\":\"https:\/\/www.globalresearch.jp\/data\/author\/globalresearch\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/","og_locale":"ja_JP","og_type":"article","og_title":"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033","og_description":"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u306e\u4e16\u754c\u5e02\u5834\u306f\u30012024\u5e74\u306b16.7\u5104\u7c73\u30c9\u30eb\u898f\u6a21\u306b\u9054\u3057\u307e\u3057\u305f\u3002IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u4e88\u6e2c\u306b\u3088\u308b\u3068\u30012033\u5e74\u306b\u306f21.2\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3057\u30012025\u5e74\u304b\u30892033\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff092.4%\u3067\u63a8\u79fb\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002 \u3053\u306e\u5e02\u5834\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u8981\u306a\u8981\u56e0\u306f\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u307e\u305a\u3001\u7d50\u6838\u306e\u767a\u751f\u7387\u5897\u52a0\u304c\u5e02\u5834\u3092\u523a\u6fc0\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u7d30\u83cc\u611f\u67d3\u75c7\u306b\u304b\u304b\u308a\u3084\u3059\u3044\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3067\u3059\u3002\u3055\u3089\u306b\u3001\u52b9\u679c\u7684\u306a\u52d5\u7269\u533b\u7642\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u9700\u8981\u306e\u9ad8\u307e\u308a\u3084\u3001\u7d99\u7d9a\u7684\u306a\u88fd\u5264\u6280\u8853\u306e\u9032\u6b69\u3082\u5e02\u5834\u306e\u62e1\u5927\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002 \u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u3057\u3066\u306f\u3001\u500b\u5225\u5316\u533b\u7642\u306e\u9032\u5c55\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u8a3a\u65ad\u304a\u3088\u3073\u30b2\u30ce\u30df\u30af\u30b9\u30c4\u30fc\u30eb\u306e\u9032\u6b69\u306b\u3088\u308a\u3001\u533b\u7642\u63d0\u4f9b\u8005\u306f\u60a3\u8005\u3054\u3068\u306b\u6700\u3082\u52b9\u679c\u7684\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u3092\u7279\u5b9a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u8033\u6bd2\u6027\u3084\u814e\u6bd2\u6027\u3068\u3044\u3063\u305f\u526f\u4f5c\u7528\u306e\u30ea\u30b9\u30af\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e743\u6708\u306b\u306fInsmed Incorporated\u304c\u3001\u30b5\u30f3\u30c7\u30a3\u30a8\u30b4\u3067\u958b\u50ac\u3055\u308c\u305f\u7c73\u56fd\u80f8\u90e8\u5b66\u4f1a\uff08ATS\uff092024\u56fd\u969b\u4f1a\u8b70\u3067\u3001\u6297\u751f\u7269\u8cea\u672a\u958b\u59cb\u306e\u518d\u767a\u6027\u307e\u305f\u306f\u65b0\u898f\u8a3a\u65ad\u306e\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\uff08MAC\uff09\u80ba\u75be\u60a3\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fARIKAYCE\u00ae\u306eARISE\u7814\u7a76\u304b\u3089\u306e\u5fae\u751f\u7269\u5b66\u7684\u30c7\u30fc\u30bf\u3092\u542b\u30809\u3064\u306e\u6284\u9332\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002 \u898f\u5236\u74b0\u5883\u306e\u5f37\u5316\u3082\u5e02\u5834\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002\u88fd\u85ac\u4f1a\u793e\u3084\u898f\u5236\u6a5f\u95a2\u306f\u3001\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u306e\u4f7f\u7528\u306b\u304a\u3051\u308b\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3068\u5b89\u5168\u6027\u306e\u5411\u4e0a\u306b\u6ce8\u529b\u3057\u3066\u304a\u308a\u3001\u6295\u4e0e\u91cf\u306e\u6700\u9069\u5316\u3068\u6709\u5bb3\u4e8b\u8c61\u306e\u6700\u5c0f\u5316\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u3057\u3044\u30d7\u30ed\u30c8\u30b3\u30eb\u3084\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u5c0e\u5165\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012024\u5e742\u6708\u306b\u306f\u3001Cipla Limited\u304c\u30a4\u30f3\u30c9\u306e\u4e2d\u592e\u533b\u85ac\u54c1\u6a19\u6e96\u7ba1\u7406\u6a5f\u69cb\uff08CDSCO\uff09\u304b\u3089\u3001\u65b0\u898f\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u9759\u8108\u5185\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u30d7\u30e9\u30be\u30de\u30a4\u30b7\u30f3\u306e\u8ca9\u58f2\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u5168\u4f53\u306e\u5c55\u671b\u3092\u63a8\u9032\u3059\u308b\u52d5\u304d\u3067\u3059\u3002 \u3055\u3089\u306b\u3001\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u3092\u542b\u3080\u4f75\u7528\u7642\u6cd5\u304c\u3001\u6cbb\u7642\u52b9\u679c\u306e\u5411\u4e0a\u3068\u6297\u751f\u7269\u8cea\u8010\u6027\u3078\u306e\u5bfe\u7b56\u3068\u3057\u3066\u6ce8\u76ee\u3092\u96c6\u3081\u3066\u3044\u307e\u3059\u3002\u4ed6\u306e\u6297\u751f\u7269\u8cea\u3068\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u533b\u7642\u63d0\u4f9b\u8005\u306f\u8907\u6570\u306e\u7d30\u83cc\u30e1\u30ab\u30cb\u30ba\u30e0\u3092\u6a19\u7684\u3068\u3057\u3001\u8010\u6027\u767a\u751f\u306e\u53ef\u80fd\u6027\u3092\u4f4e\u6e1b\u3067\u304d\u307e\u3059\u30022024\u5e747\u6708\u306b\u306f\u3001Orchid Pharma Limited\u304c\u3001\u8907\u96d1\u306a\u9662\u5185\u80ba\u708e\uff08HAP\uff09\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\uff08cUTI\uff09\u3001\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\uff08VAP\uff09\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u65b0\u85acCefepime-Enmetazobactam\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002 \u5730\u7406\u7684\u30c8\u30ec\u30f3\u30c9\u3092\u898b\u308b\u3068\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u52b9\u679c\u7684\u306a\u6297\u83cc\u6cbb\u7642\u9078\u629e\u80a2\u306e\u666e\u53ca\u3068\u3001\u4fa1\u5024\u3042\u308b\u6cbb\u7642\u85ac\u3078\u306e\u9700\u8981\u5897\u52a0\u304c\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u3044\u307e\u3059\u3002 \u5e02\u5834\u306b\u304a\u3051\u308b\u8ab2\u984c\u3068\u3057\u3066\u306f\u3001\u814e\u6bd2\u6027\u767a\u73fe\u306e\u30ea\u30b9\u30af\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u526f\u4f5c\u7528\u3092\u6700\u5c0f\u9650\u306b\u6291\u3048\u308b\u52b9\u7387\u7684\u306a\u9001\u9054\u65b9\u6cd5\u306e\u5c0e\u5165\u304c\u3001\u4eca\u5f8c\u306e\u5e02\u5834\u3092\u727d\u5f15\u3059\u308b\u91cd\u8981\u306a\u6a5f\u4f1a\u3068\u306a\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u7af6\u4e89\u74b0\u5883\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd\u3001Vega Group company limited\u306a\u3069\u3001\u591a\u6570\u306e\u8457\u540d\u4f01\u696d\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002 IMARC\u30b0\u30eb\u30fc\u30d7\u306e\u5206\u6790\u306b\u3088\u308b\u3068\u3001\u5e02\u5834\u306f\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u306b\u57fa\u3065\u3044\u3066\u5206\u985e\u3055\u308c\u307e\u3059\u3002\u88fd\u54c1\u5225\u3067\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u7279\u306b\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u3067\u6700\u5927\u306e\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002 \u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u5831\u544a\u66f8\u306b\u3088\u308b\u3068\u3001\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u3001\u5730\u57df\u5225\u306b\u5e02\u5834\u304c\u7d30\u5206\u5316\u3055\u308c\u3001\u305d\u308c\u305e\u308c\u306e\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u304c\u7279\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u88fd\u54c1\u5225\u5e02\u5834\u3067\u306f\u3001\u5f37\u529b\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u304c\u6700\u5927\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30ab\u30c6\u30b4\u30ea\u30fc\u306b\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u3082\u542b\u307e\u308c\u307e\u3059\u3002Xellia Pharmaceuticals\u306f\u3001\u75c5\u9662\u74b0\u5883\u3067\u5e83\u304f\u63a1\u7528\u3055\u308c\u3066\u3044\u308b\u6ce8\u5c04\u5264\u3092\u542b\u3080\u3001\u591a\u69d8\u306a\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u88fd\u54c1\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002 \u6295\u4e0e\u7d4c\u8def\u5225\u3067\u306f\u3001\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u9700\u8981\u306b\u304a\u3044\u3066\u5727\u5012\u7684\u306a\u512a\u4f4d\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u6210\u9577\u306f\u3001\u60a3\u8005\u306b\u3068\u3063\u3066\u3088\u308a\u5b89\u5168\u3067\u52b9\u679c\u7684\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3092\u958b\u767a\u3059\u308b\u5fc5\u8981\u6027\u306e\u9ad8\u307e\u308a\u306b\u3088\u3063\u3066\u727d\u5f15\u3055\u308c\u3066\u304a\u308a\u3001\u4f8b\u3048\u3070Hikma Pharmaceuticals\u306f\u6551\u547d\u6551\u6025\u74b0\u5883\u5411\u3051\u306e\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def\u306b\u306f\u3001\u4e73\u623f\u5185\u6295\u4e0e\u3001\u5c40\u6240\u6295\u4e0e\u3001\u7d4c\u53e3\u6295\u4e0e\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u3002 \u7528\u9014\u5225\u5e02\u5834\u3067\u306f\u3001\u547c\u5438\u5668\u75be\u60a3\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u53ce\u76ca\u306b\u304a\u3044\u3066\u6700\u5927\u306e\u5272\u5408\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u3002\u547c\u5438\u5668\u75be\u60a3\u3068\u306e\u95d8\u3044\u306b\u5bfe\u3059\u308b\u4e16\u754c\u7684\u306a\u8981\u6c42\u306e\u9ad8\u307e\u308a\u304c\u5e02\u5834\u3092\u6d3b\u6027\u5316\u3055\u305b\u3066\u304a\u308a\u3001\u3053\u308c\u3089\u306e\u6297\u751f\u7269\u8cea\u3092\u80ba\u306b\u76f4\u63a5\u9001\u9054\u3059\u308b\u6700\u9069\u5316\u3082\u76ee\u6307\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u306b\u306f\u3001\u7363\u533b\u7528\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u306a\u3069\u306e\u7528\u9014\u3082\u542b\u307e\u308c\u307e\u3059\u3002 \u5730\u57df\u5225\u5e02\u5834\u5206\u6790\u3067\u306f\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u5e02\u5834\u306b\u304a\u3044\u3066\u660e\u78ba\u306a\u512a\u4f4d\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5730\u57df\u306f\u3001\u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u306a\u3069\uff09\u3001\u4e2d\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30e1\u30ad\u30b7\u30b3\u306a\u3069\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3068\u3044\u3063\u305f\u4e3b\u8981\u5e02\u5834\u3068\u3068\u3082\u306b\u5305\u62ec\u7684\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u3067\u306f\u3001\u6162\u6027\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u767a\u751f\u7387\u5897\u52a0\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u306e\u6210\u9577\u3092\u5f37\u529b\u306b\u63a8\u9032\u3057\u3066\u304a\u308a\u3001\u6025\u901f\u306b\u62e1\u5927\u3059\u308b\u88fd\u85ac\u7523\u696d\u3082\u91cd\u8981\u306a\u6210\u9577\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002IMARC\u306e\u5831\u544a\u306b\u3088\u308b\u3068\u3001\u30a4\u30f3\u30c9\u306e\u88fd\u85ac\u5e02\u5834\u898f\u6a21\u306f2023\u5e74\u306b546\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012024\u5e74\u304b\u30892032\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0912.3%\u3067\u6210\u9577\u3057\u30012032\u5e74\u306b\u306f1631\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002 \u7af6\u4e89\u74b0\u5883\u3068\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u65b0\u3057\u3044\u6295\u4e0e\u65b9\u6cd5\u306e\u958b\u767a\u3001\u65b0\u898f\u7528\u9014\u306e\u63a2\u6c42\u3001\u65e2\u5b58\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u88fd\u5264\u306e\u6539\u5584\u3078\u306e\u7a4d\u6975\u7684\u306a\u6295\u8cc7\u304c\u5e02\u5834\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4f01\u696d\u306f\u307e\u305f\u3001\u88fd\u54c1\u306e\u5b89\u5168\u6027\u3092\u8a55\u4fa1\u3059\u308b\u305f\u3081\u306e\u81e8\u5e8a\u8a66\u9a13\u3092\u7cbe\u529b\u7684\u306b\u5b9f\u65bd\u3057\u3066\u304a\u308a\u3001\u3053\u308c\u304c\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u5e02\u5834\u5168\u4f53\u306e\u5c55\u671b\u306b\u826f\u3044\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd.\u3001Vega Group company limited\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002 \u6700\u8fd1\u306e\u52d5\u5411\u3068\u3057\u3066\u30012024\u5e747\u6708\u306b\u306f\u3001Orchid Pharma Limited\u304c\u8907\u96d1\u306a\u611f\u67d3\u75c7\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u305f\u65b0\u85acCefepime-Enmetazobactam\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002 \u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u306f\u3001\u6700\u8fd1\u306e\u52d5\u5411\u3068\u3057\u3066\u30012024\u5e743\u6708\u306bInsmed\u793e\u304c\u7c73\u56fd\u80f8\u90e8\u5b66\u4f1a\uff08ATS\uff092024\u56fd\u969b\u4f1a\u8b70\u3067\u3001\u6297\u751f\u7269\u8cea\u672a\u6295\u4e0e\u306e\u518d\u767a\u6027\u307e\u305f\u306f\u65b0\u898f\u8a3a\u65ad\u306e\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\uff08MAC\u80ba\u75be\u60a3\uff09\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fARIKAYCE\u00ae\uff08\u30a2\u30df\u30ab\u30b7\u30f3\u30ea\u30dd\u30bd\u30fc\u30e0\u5438\u5165\u61f8\u6fc1\u6db2\uff09\u306eARISE\u8a66\u9a13\u306e\u5fae\u751f\u7269\u5b66\u7684\u30c7\u30fc\u30bf\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u30012024\u5e742\u6708\u306b\u306f\u3001Cipla\u793e\u304c\u30a4\u30f3\u30c9\u3067\u65b0\u898f\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u3067\u3042\u308b\u9759\u8108\u5185\u6295\u4e0e\u306e\u30d7\u30e9\u30be\u30de\u30a4\u30b7\u30f3\u306b\u3064\u3044\u3066\u3001\u9662\u5185\u80ba\u708e\uff08HAP\uff09\u3001\u8907\u96d1\u6027\u5c3f\u8def\u611f\u67d3\u75c7\uff08cUTI\uff09\u3001\u4eba\u5de5\u547c\u5438\u5668\u95a2\u9023\u80ba\u708e\uff08VAP\uff09\u306e\u9069\u5fdc\u3067\u4e2d\u592e\u533b\u85ac\u54c1\u57fa\u6e96\u7ba1\u7406\u6a5f\u69cb\uff08CDSCO\uff09\u306e\u627f\u8a8d\u3092\u53d7\u3051\u3001\u8ca9\u58f2\u4fc3\u9032\u304c\u53ef\u80fd\u3068\u306a\u308a\u307e\u3057\u305f\u3002 \u3053\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u30ec\u30dd\u30fc\u30c8\u306f\u30012024\u5e74\u3092\u57fa\u6e96\u5e74\u3068\u3057\u30012019\u5e74\u304b\u30892024\u5e74\u307e\u3067\u306e\u904e\u53bb\u306e\u671f\u9593\u3068\u30012025\u5e74\u304b\u30892033\u5e74\u307e\u3067\u306e\u4e88\u6e2c\u671f\u9593\u3092\u5bfe\u8c61\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u898f\u6a21\u306f\u6570\u5341\u5104\u7c73\u30c9\u30eb\u5358\u4f4d\u3067\u8a55\u4fa1\u3055\u308c\u3001\u904e\u53bb\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u5e02\u5834\u898b\u901a\u3057\u3001\u696d\u754c\u306e\u4fc3\u9032\u8981\u56e0\u3068\u8ab2\u984c\u3001\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u306e\u904e\u53bb\u304a\u3088\u3073\u4e88\u6e2c\u5e02\u5834\u8a55\u4fa1\u3092\u8a73\u7d30\u306b\u5206\u6790\u3057\u307e\u3059\u3002 \u30ec\u30dd\u30fc\u30c8\u3067\u30ab\u30d0\u30fc\u3055\u308c\u308b\u88fd\u54c1\u306b\u306f\u3001\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u6295\u4e0e\u7d4c\u8def\u306f\u3001\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u6295\u4e0e\u3001\u5c40\u6240\u6295\u4e0e\u3001\u7d4c\u53e3\u6295\u4e0e\u3001\u305d\u306e\u4ed6\u591a\u5c90\u306b\u308f\u305f\u308a\u307e\u3059\u3002\u4e3b\u306a\u7528\u9014\u3068\u3057\u3066\u306f\u3001\u7363\u533b\u5206\u91ce\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3001\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab\u304c\u5bfe\u8c61\u3068\u306a\u308a\u3001\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30c9\u30a4\u30c4\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u82f1\u56fd\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u3001\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u97d3\u56fd\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u30a4\u30f3\u30c9\u30cd\u30b7\u30a2\u3001\u30d6\u30e9\u30b8\u30eb\u3001\u30e1\u30ad\u30b7\u30b3\u3068\u3044\u3063\u305f\u4e3b\u8981\u56fd\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u307e\u3059\u3002 \u5e02\u5834\u306e\u4e3b\u8981\u4f01\u696d\u306b\u306f\u3001Huvepharma NV\u3001Kremoint Pharma Pvt. Ltd.\u3001Novartis AG\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Ltd\u3001Vega Group company limited\u306a\u3069\u304c\u540d\u3092\u9023\u306d\u3066\u3044\u307e\u3059\u3002 \u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u304c\u3053\u308c\u307e\u3067\u3069\u306e\u3088\u3046\u306b\u63a8\u79fb\u3057\u3001\u4eca\u5f8c\u3069\u306e\u3088\u3046\u306b\u5c55\u958b\u3059\u308b\u304b\u3001\u5e02\u5834\u306e\u4fc3\u9032\u8981\u56e0\u3001\u6291\u5236\u8981\u56e0\u3001\u6a5f\u4f1a\u3001\u304a\u3088\u3073\u305d\u308c\u3089\u304c\u5e02\u5834\u6210\u9577\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u6df1\u304f\u6398\u308a\u4e0b\u3052\u307e\u3059\u3002\u307e\u305f\u3001\u4e3b\u8981\u306a\u5730\u57df\u5e02\u5834\u3001\u6700\u3082\u9b45\u529b\u7684\u306a\u56fd\u3001\u88fd\u54c1\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u5225\u306e\u5e02\u5834\u306e\u5185\u8a33\u3001\u304a\u3088\u3073\u305d\u308c\u305e\u308c\u306e\u6700\u3082\u9b45\u529b\u7684\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u3092\u7279\u5b9a\u3057\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u306e\u7af6\u4e89\u69cb\u9020\u3068\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u306b\u3064\u3044\u3066\u3082\u8a73\u7d30\u306b\u89e3\u8aac\u3057\u307e\u3059\u3002 \u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306f\u3001IMARC\u306e\u30ec\u30dd\u30fc\u30c8\u3092\u901a\u3058\u3066\u30012019\u5e74\u304b\u30892033\u5e74\u307e\u3067\u306e\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u85ac\u5264\u5e02\u5834\u306b\u95a2\u3059\u308b\u5305\u62ec\u7684\u306a\u5b9a\u91cf\u7684\u5206\u6790\u3001\u6700\u65b0\u306e\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3001\u4e88\u6e2c\u3001\u30c0\u30a4\u30ca\u30df\u30af\u30b9\u3092\u5f97\u3089\u308c\u307e\u3059\u3002\u5e02\u5834\u306e\u4fc3\u9032\u8981\u56e0\u3001\u8ab2\u984c\u3001\u6a5f\u4f1a\u306b\u95a2\u3059\u308b\u60c5\u5831\u306b\u52a0\u3048\u3001\u4e3b\u8981\u306a\u5730\u57df\u304a\u3088\u3073\u56fd\u30ec\u30d9\u30eb\u306e\u5e02\u5834\u3092\u7279\u5b9a\u3067\u304d\u307e\u3059\u3002\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u306b\u3088\u308a\u3001\u65b0\u898f\u53c2\u5165\u8005\u3001\u7af6\u4e89\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u30fb\u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3092\u8a55\u4fa1\u3057\u3001\u696d\u754c\u306e\u7af6\u4e89\u30ec\u30d9\u30eb\u3068\u9b45\u529b\u3092\u5206\u6790\u53ef\u80fd\u3067\u3059\u3002\u307e\u305f\u3001\u7af6\u4e89\u74b0\u5883\u306e\u5206\u6790\u3092\u901a\u3058\u3066\u3001\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u306e\u5e02\u5834\u306b\u304a\u3051\u308b\u73fe\u5728\u306e\u4f4d\u7f6e\u3092\u7406\u89e3\u3057\u3001\u7af6\u4e89\u6226\u7565\u3092\u7b56\u5b9a\u3059\u308b\u305f\u3081\u306e\u6d1e\u5bdf\u3092\u5f97\u3089\u308c\u307e\u3059\u3002","og_url":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/","og_site_name":"GlobalResearch.jp","article_published_time":"2026-02-06T08:40:45+00:00","article_modified_time":"2026-02-24T01:26:35+00:00","og_image":[{"url":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp"}],"author":"globalresearch","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"globalresearch","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/","url":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/","name":"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033","isPartOf":{"@id":"https:\/\/www.marketreport.jp\/insight\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#primaryimage"},"image":{"@id":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp","datePublished":"2026-02-06T08:40:45+00:00","dateModified":"2026-02-24T01:26:35+00:00","author":{"@id":"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4"},"breadcrumb":{"@id":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#primaryimage","url":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp","contentUrl":"https:\/\/www.globalresearch.jp\/data\/wp-content\/uploads\/2026\/02\/3f05002b-bdc0-4fd8-9fc1-d11d36db9896aminoglycosides-market-region1.webp","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.globalresearch.jp\/data\/aminoglycosides-market-imarc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.globalresearch.jp\/data\/"},{"@type":"ListItem","position":2,"name":"\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\uff1a\u88fd\u54c1\u5225\uff08\u30cd\u30aa\u30de\u30a4\u30b7\u30f3\u3001\u30c8\u30d6\u30e9\u30de\u30a4\u30b7\u30f3\u3001\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u3001\u30a2\u30df\u30ab\u30b7\u30f3\u3001\u30d1\u30ed\u30e2\u30de\u30a4\u30b7\u30f3\u3001\u30b9\u30c8\u30ec\u30d7\u30c8\u30de\u30a4\u30b7\u30f3\u3001\u30ab\u30ca\u30de\u30a4\u30b7\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6295\u4e0e\u7d4c\u8def\u5225\uff08\u6ce8\u5c04\u5264\uff08\u975e\u7d4c\u53e3\uff09\u3001\u4e73\u623f\u5185\u3001\u5c40\u6240\u3001\u7d4c\u53e3\u3001\u305d\u306e\u4ed6\uff09\u3001\u7528\u9014\u5225\uff08\u7363\u533b\u3001\u76ae\u819a\u611f\u67d3\u75c7\u3001\u547c\u5438\u5668\u75be\u60a3\u3001\u5c3f\u8def\u611f\u67d3\u75c7\u304a\u3088\u3073\u9aa8\u76e4\u75be\u60a3\u3001\u305d\u306e\u4ed6\uff09\u3001\u304a\u3088\u3073\u5730\u57df\u52252025-2033"}]},{"@type":"WebSite","@id":"https:\/\/www.marketreport.jp\/insight\/#website","url":"https:\/\/www.marketreport.jp\/insight\/","name":"GlobalResearch.jp","description":"\u2756\u30b0\u30ed\u30fc\u30d0\u30eb\u8abf\u67fb\u30ec\u30dd\u30fc\u30c8\u8ca9\u58f2\u30b5\u30a4\u30c8\u2756","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketreport.jp\/insight\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/bce0a2e35028a53aca02d7a79eab25b4","name":"globalresearch","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.marketreport.jp\/insight\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7e215553eb432f19e4d8efa197326c46?s=96&d=mm&r=g","caption":"globalresearch"},"sameAs":["https:\/\/www.marketreport.jp\/insight"],"url":"https:\/\/www.globalresearch.jp\/data\/author\/globalresearch\/"}]}},"_links":{"self":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/posts\/60190"}],"collection":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/comments?post=60190"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/posts\/60190\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/media?parent=60190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/categories?post=60190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.jp\/data\/wp-json\/wp\/v2\/tags?post=60190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}